These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20045956)

  • 1. The disposition of pravastatin in a rat model of streptozotocin-induced diabetes and organic anion transporting polypeptide 2 and multidrug resistance-associated protein 2 expression in the liver.
    Hasegawa Y; Kishimoto S; Shibatani N; Inotsume N; Takeuchi Y; Fukushima S
    Biol Pharm Bull; 2010; 33(1):153-6. PubMed ID: 20045956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of High-cholesterol Diet on Pravastatin Disposition in the Perfused Rat Liver.
    Kawase A; Handa A; Iwaki M
    Eur J Drug Metab Pharmacokinet; 2017 Jun; 42(3):519-526. PubMed ID: 27511381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of morphine and its glucuronide conjugate in a rat model of streptozotocin-induced diabetes and the expression of MRP2, MRP3 and UGT2B1 in the liver.
    Hasegawa Y; Kishimoto S; Shibatani N; Nomura H; Ishii Y; Onishi M; Inotsume N; Takeuchi Y; Fukushima S
    J Pharm Pharmacol; 2010 Mar; 62(3):310-4. PubMed ID: 20487213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential expression of bile salt and organic anion transporters in developing rat liver.
    Gao B; St Pierre MV; Stieger B; Meier PJ
    J Hepatol; 2004 Aug; 41(2):201-8. PubMed ID: 15288467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic interaction between genetics and disease on pravastatin disposition.
    Clarke JD; Hardwick RN; Lake AD; Lickteig AJ; Goedken MJ; Klaassen CD; Cherrington NJ
    J Hepatol; 2014 Jul; 61(1):139-47. PubMed ID: 24613363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of serum in hemodialysis patients on the expression of intestinal and hepatic transporters for the excretion of pravastatin.
    Tsujimoto M; Hatozaki D; Shima D; Yokota H; Furukubo T; Izumi S; Yamakawa T; Minegaki T; Nishiguchi K
    Ther Apher Dial; 2012 Dec; 16(6):580-7. PubMed ID: 23190519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hepatic transport and metabolism in the interactions between pravastatin or repaglinide and two rOatp inhibitors in rats.
    Badolo L; Bundgaard C; Garmer M; Jensen B
    Eur J Pharm Sci; 2013 Jul; 49(4):767-72. PubMed ID: 23648783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of transporters in the hepatic uptake and biliary excretion of valsartan, a selective antagonist of the angiotensin II AT1-receptor, in humans.
    Yamashiro W; Maeda K; Hirouchi M; Adachi Y; Hu Z; Sugiyama Y
    Drug Metab Dispos; 2006 Jul; 34(7):1247-54. PubMed ID: 16624871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recommendation to Exclude Bile-Duct-Cannulated Rats with Hyperbilirubinemia for Proper Conduct of Biliary Drug Excretion Studies.
    Kato K; Hasegawa Y; Iwata K; Ichikawa T; Yahara T; Tsuji S; Sugiura M; Yamaguchi J
    Drug Metab Dispos; 2016 Aug; 44(8):1180-3. PubMed ID: 27208382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of Contribution of Multidrug Resistance-associated Protein and Organic Anion-transporting Polypeptide to Pharmacokinetics of Regorafenib, a Novel Multi-Kinase Inhibitor, in Rats.
    Hotta K; Ueyama J; Tatsumi Y; Tsukiyama I; Sugiura Y; Saito H; Matsuura K; Hasegawa T
    Anticancer Res; 2015 Sep; 35(9):4681-9. PubMed ID: 26254357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug transporters are altered in brain, liver and kidney of rats with chronic epilepsy induced by lithium-pilocarpine.
    Guo Y; Jiang L
    Neurol Res; 2010 Feb; 32(1):106-12. PubMed ID: 19570321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy.
    Cao J; Stieger B; Meier PJ; Vore M
    Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G757-66. PubMed ID: 12181192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of genetic polymorphism in ABCC2 with hepatic multidrug resistance-associated protein 2 expression and pravastatin pharmacokinetics.
    Niemi M; Arnold KA; Backman JT; Pasanen MK; Gödtel-Armbrust U; Wojnowski L; Zanger UM; Neuvonen PJ; Eichelbaum M; Kivistö KT; Lang T
    Pharmacogenet Genomics; 2006 Nov; 16(11):801-8. PubMed ID: 17047488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pravastatin, an HMG-CoA reductase inhibitor, is transported by rat organic anion transporting polypeptide, oatp2.
    Tokui T; Nakai D; Nakagomi R; Yawo H; Abe T; Sugiyama Y
    Pharm Res; 1999 Jun; 16(6):904-8. PubMed ID: 10397612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender-specific expression of liver organic anion transporters in rat.
    Rost D; Kopplow K; Gehrke S; Mueller S; Friess H; Ittrich C; Mayer D; Stiehl A
    Eur J Clin Invest; 2005 Oct; 35(10):635-43. PubMed ID: 16178883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide.
    Shirasaka Y; Suzuki K; Nakanishi T; Tamai I
    Pharm Res; 2010 Oct; 27(10):2141-9. PubMed ID: 20686826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of transporters in the disposition of the selective phosphodiesterase-4 inhibitor (+)-2-[4-({[2-(benzo[1,3]dioxol-5-yloxy)-pyridine-3-carbonyl]-amino}-methyl)-3-fluoro-phenoxy]-propionic acid in rat and human.
    Kalgutkar AS; Feng B; Nguyen HT; Frederick KS; Campbell SD; Hatch HL; Bi YA; Kazolias DC; Davidson RE; Mireles RJ; Duignan DB; Choo EF; Zhao SX
    Drug Metab Dispos; 2007 Nov; 35(11):2111-8. PubMed ID: 17686907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interplay of phase II enzymes and transporters in futile cycling: influence of multidrug resistance-associated protein 2-mediated excretion of estradiol 17beta-D-glucuronide and its 3-sulfate metabolite on net sulfation in perfused TR(-) and Wistar rat liver preparations.
    Sun H; Zeng YY; Pang KS
    Drug Metab Dispos; 2010 May; 38(5):769-80. PubMed ID: 20124397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.
    Hsiang B; Zhu Y; Wang Z; Wu Y; Sasseville V; Yang WP; Kirchgessner TG
    J Biol Chem; 1999 Dec; 274(52):37161-8. PubMed ID: 10601278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of the hepatic efflux transporters of organic anions using double-transfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistance-associated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast cancer resistance protein.
    Matsushima S; Maeda K; Kondo C; Hirano M; Sasaki M; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1059-67. PubMed ID: 15901800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.